Although price cut playing cards might help alleviate the burden of high drug expenditures from the short-term, they don't deal with the systemic concerns driving up prescription price ranges in the U.S. Broader policy changes could deal with the foundation leads to of climbing drug rates, including not enough transparency in pricing and also the r